Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington; and.
Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington; and
J Am Soc Nephrol. 2018 Aug;29(8):2157-2167. doi: 10.1681/ASN.2018030265. Epub 2018 Jul 6.
Recent clinical data support the utility/superiority of a new AKI biomarker ("NephroCheck"), the arithmetic product of urinary TIMP × IGFBP7 concentrations. However, the pathophysiologic basis for its utility remains ill defined.
To clarify this issue, CD-1 mice were subjected to either nephrotoxic (glycerol, maleate) or ischemic AKI. Urinary TIMP2/IGFBP7 concentrations were determined at 4 and 18 hours postinjury and compared with urinary albumin levels. Gene transcription was assessed by measuring renal cortical and/or medullary TIMP2/IGFBP7 mRNAs (4 and 18 hours after AKI induction). For comparison, the mRNAs of three renal "stress" biomarkers (NGAL, heme oxygenase 1, and p21) were assessed. Renal cortical TIMP2/IGFBP7 protein was gauged by ELISA. Proximal tubule-specific TIMP2/IGFBP7 was assessed by immunohistochemistry.
Each AKI model induced prompt (4 hours) and marked urinary TIMP2/IGFBP7 increases without an increase in renal cortical concentrations. Furthermore, TIMP2/IGFBP7 mRNAs remained at normal levels. Endotoxemia also failed to increase TIMP2/IGFBP7 mRNAs. In contrast, each AKI model provoked massive NGAL, HO-1, and p21 mRNA increases, confirming that a renal "stress response" had occurred. Urinary albumin rose up to 100-fold and strongly correlated (=0.87-0.91) with urinary TIMP2/IGFBP7 concentrations. Immunohistochemistry showed progressive TIMP2/IGFBP7 losses from injured proximal tubule cells. Competitive inhibition of endocytic protein reabsorption in normal mice tripled urinary TIMP2/IGFBP7 levels, confirming this pathway's role in determining urinary excretion.
AKI-induced urinary TIMP2/IGFBP7 elevations are not due to stress-induced gene transcription. Rather, increased filtration, decreased tubule reabsorption, and proximal tubule cell TIMP2/IGFBP7 urinary leakage seem to be the most likely mechanisms.
最近的临床数据支持一种新的急性肾损伤(AKI)生物标志物(“NephroCheck”)的实用性/优越性,它是尿 TIMP×IGFBP7 浓度的乘积。然而,其实用性的病理生理基础仍未明确。
为了解决这个问题,将 CD-1 小鼠进行肾毒性(甘油、马来酸)或缺血性 AKI 处理。在损伤后 4 小时和 18 小时测定尿 TIMP2/IGFBP7 浓度,并与尿白蛋白水平进行比较。通过测量肾皮质和/或髓质 TIMP2/IGFBP7 mRNA(AKI 诱导后 4 小时和 18 小时)评估基因转录。为了进行比较,还评估了三种肾“应激”生物标志物(NGAL、血红素加氧酶 1 和 p21)的 mRNA。通过 ELISA 测定肾皮质 TIMP2/IGFBP7 蛋白。通过免疫组化评估近端肾小管特异性 TIMP2/IGFBP7。
每种 AKI 模型均诱导尿 TIMP2/IGFBP7 迅速(4 小时)和显著增加,而肾皮质浓度无增加。此外,TIMP2/IGFBP7 mRNA 仍保持正常水平。内毒素血症也未能增加 TIMP2/IGFBP7 mRNA。相比之下,每种 AKI 模型均引起大量的 NGAL、HO-1 和 p21 mRNA 增加,证实发生了肾“应激反应”。尿白蛋白增加高达 100 倍,与尿 TIMP2/IGFBP7 浓度强烈相关(=0.87-0.91)。免疫组化显示受损的近端肾小管细胞中 TIMP2/IGFBP7 逐渐丢失。在正常小鼠中竞争性抑制内吞蛋白再吸收使尿 TIMP2/IGFBP7 水平增加三倍,证实了该途径在决定尿排泄中的作用。
AKI 诱导的尿 TIMP2/IGFBP7 升高不是由应激诱导的基因转录引起的。相反,增加的滤过、减少的肾小管重吸收和近端肾小管细胞 TIMP2/IGFBP7 尿漏似乎是最可能的机制。